William E. Carson

20.7k total citations · 2 hit papers
313 papers, 14.2k citations indexed

About

William E. Carson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, William E. Carson has authored 313 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Oncology, 137 papers in Immunology and 82 papers in Molecular Biology. Recurrent topics in William E. Carson's work include Immune Cell Function and Interaction (76 papers), Immunotherapy and Immune Responses (38 papers) and Cancer Immunotherapy and Biomarkers (36 papers). William E. Carson is often cited by papers focused on Immune Cell Function and Interaction (76 papers), Immunotherapy and Immune Responses (38 papers) and Cancer Immunotherapy and Biomarkers (36 papers). William E. Carson collaborates with scholars based in United States, China and Canada. William E. Carson's co-authors include Michael A. Caligiuri, Todd A. Fehniger, Barbara L. Andersen, Robin Parihar, Joseph Markowitz, William B. Farrar, Lisa M. Thornton, Megan A. Cooper, Robert Wesolowski and Gregory B. Lesinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

William E. Carson

307 papers receiving 13.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

2001 1.1k citations William E. Carson, Michael A. Caligiuri et al. profile →
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

1994 943 citations William E. Carson, Michael A. Caligiuri et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
William E. Carson	7.3k	5.6k	3.1k	1.4k	1.0k	313	14.2k
Angela Santoni	12.2k 1.7×	5.2k 0.9×	5.2k 1.7×	1.3k 0.9×	762 0.7×	406	19.9k
Joachim L. Schultze	11.0k 1.5×	3.7k 0.7×	6.5k 2.1×	1.4k 1.1×	1.1k 1.1×	284	20.1k
Éric Tartour	8.6k 1.2×	8.3k 1.5×	4.1k 1.3×	1.4k 1.0×	777 0.8×	263	15.3k
Dennis D. Taub	7.5k 1.0×	3.8k 0.7×	4.5k 1.5×	993 0.7×	513 0.5×	235	17.9k
Andrew L. Mellor	16.3k 2.2×	5.3k 0.9×	7.2k 2.3×	1.3k 0.9×	700 0.7×	228	31.1k
David A. Fox	6.7k 0.9×	2.0k 0.4×	3.3k 1.1×	736 0.5×	1.1k 1.1×	230	13.4k
Takehiko Sasazuki	8.2k 1.1×	2.9k 0.5×	5.8k 1.9×	1.7k 1.3×	1.4k 1.4×	351	18.7k
Christopher Power	8.3k 1.1×	5.3k 0.9×	6.8k 2.2×	1.7k 1.2×	1.5k 1.5×	374	26.0k
Stephan Lang	4.4k 0.6×	3.6k 0.6×	2.8k 0.9×	1.3k 0.9×	491 0.5×	375	11.0k
Andrew H. Lichtman	8.8k 1.2×	3.0k 0.5×	4.1k 1.3×	840 0.6×	391 0.4×	154	15.8k

Countries citing papers authored by William E. Carson

Since Specialization

Citations

This map shows the geographic impact of William E. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Carson more than expected).

Fields of papers citing papers by William E. Carson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Carson. The network helps show where William E. Carson may publish in the future.

Co-authorship network of co-authors of William E. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Carson. A scholar is included among the top collaborators of William E. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Carson. William E. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwarz, Emily, et al.. (2025). Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer. Cancer Immunology Research. 13(4). 560–576. 2 indexed citations

Elsaid, Mohamed I., Jesse J. Plascak, Barbara L. Andersen, et al.. (2023). The Implications of Racialized Economic Segregation and Allostatic Load on Mortality in Patients with Breast Cancer. Annals of Surgical Oncology. 31(1). 365–375. 8 indexed citations

Li, Roger, et al.. (2023). Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients’ access to novel therapeutics. Urologic Oncology Seminars and Original Investigations. 41(9). 390.e1–390.e17. 1 indexed citations

Hu, Zhiwei, Rulong Shen, Elizabeth L. McMichael, et al.. (2018). Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON. Cancer Immunology Research. 6(6). 671–684. 33 indexed citations

Campbell, Amanda R., Megan Duggan, Lorena P. Suarez‐Kelly, et al.. (2017). MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions. Cancer Immunology Research. 5(9). 778–789. 15 indexed citations

Bertino, Erin M., Elizabeth L. McMichael, Xiaokui Mo, et al.. (2016). A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer. Molecular Cancer Therapeutics. 15(9). 2244–2250. 22 indexed citations

Andersen, Barbara L., et al.. (2016). Trajectories of Stress, Depressive Symptoms, and Immunity in Cancer Survivors: Diagnosis to 5 Years. Clinical Cancer Research. 23(1). 52–61. 36 indexed citations

McMichael, Elizabeth L., Alena Cristina Jaime‐Ramirez, Kristan Guenterberg, et al.. (2016). IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells. Clinical Cancer Research. 23(2). 489–502. 55 indexed citations

Nasser, Mohd W., Nissar Ahmad Wani, Dinesh K. Ahirwar, et al.. (2015). RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment. Cancer Research. 75(6). 974–985. 124 indexed citations

10.

Wesolowski, Robert & William E. Carson. (2014). Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer. Journal of Carcinogenesis & Mutagenesis. 5(6). 7 indexed citations

11.

Choi, Yong Seok, Jin Kyun Park, Eun Ha Kang, et al.. (2013). Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta. Arthritis Research & Therapy. 15(6). R191–R191. 23 indexed citations

12.

Mundy-Bosse, Bethany L., Gregory B. Lesinski, Alena Cristina Jaime‐Ramirez, et al.. (2011). Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice. Cancer Research. 71(15). 5101–5110. 149 indexed citations

13.

Kim, Kevin B., Jeffrey A. Sosman, John P. Fruehauf, et al.. (2011). BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma. Journal of Clinical Oncology. 30(1). 34–41. 148 indexed citations

14.

Zimmerer, Jason M., Gregory B. Lesinski, Amy S. Ruppert, et al.. (2008). Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α. Clinical Cancer Research. 14(18). 5900–5906. 27 indexed citations

15.

Lesinski, Gregory B., Kristan Guenterberg, Michael R. Go, et al.. (2008). IFN-α and Bortezomib Overcome Bcl-2 and Mcl-1 Overexpression in Melanoma Cells by Stimulating the Extrinsic Pathway of Apoptosis. Cancer Research. 68(20). 8351–8360. 44 indexed citations

16.

Lesinski, Gregory B., John C. Trefry, Sri Vidya Kondadasula, et al.. (2007). Melanoma Cells Exhibit Variable Signal Transducer and Activator of Transcription 1 Phosphorylation and a Reduced Response to IFN-α Compared with Immune Effector Cells. Clinical Cancer Research. 13(17). 5010–5019. 30 indexed citations

17.

Lesinski, Gregory B., Mirela Anghelina, Jason M. Zimmerer, et al.. (2003). The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse. Journal of Clinical Investigation. 112(2). 170–180. 97 indexed citations

18.

Parihar, Robin, Julie Dierksheide, Yan Hu, & William E. Carson. (2002). IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. Journal of Clinical Investigation. 110(7). 983–992. 16 indexed citations

19.

Parihar, Robin, et al.. (2002). IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. Journal of Clinical Investigation. 110(7). 983–992. 137 indexed citations

20.

Carson, William E.. (1998). Social Change and Rational Choice: A Contemporary Interpretation of the Amish. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact